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In case diseases of food-producing animals or zoonoses (re-)emerge, early clinical decision 25 
making is of major importance. In this particular condition, it is difficult to apply a classical 26 
evidence-based veterinary medicine process, because of a lack of available published data. A 27 
method based on the partition of field clinical observations (evidences) could be developed as 28 
an interesting alternative approach. The classification and regression tree (CART) analysis 29 
was used to improve the early clinical detection of two selected emerging diseases: bovine 30 
spongiform encephalopathy (mad cow disease) and bluetongue due to the serotype 8-virus in 31 
cattle.  32 
 33 
ABSTRACT 34 
Background: In case diseases of food-producing animals or zoonoses (re-)emerge, early 35 
clinical decision making is of major importance. In this particular condition, it is difficult to 36 
apply a classical evidence-based veterinary medicine process, because of a lack of available 37 
published data. Objective: A method based on the partition of field clinical observations 38 
(evidences) could be developed as an interesting alternative approach. Method and principal 39 
findings: The classification and regression tree (CART) analysis was used to improve the 40 
early clinical detection of two selected emerging diseases: bovine spongiform encephalopathy 41 
(mad cow disease) and bluetongue due to the serotype 8-virus in cattle. Conclusion and 42 
significance: The use of CART analysis is a way to improve the early clinical detection of 43 
diseases of food-producing animals or zoonoses as well as conditions of emergence. The 44 
development of a veterinary structured, informed and interactive clinical platform is highly 45 






Evidence-based veterinary medicine (EBVM) is the application of evidence-based 50 
medicine (EBM) to the veterinary field (1). By definition, it is the conscientious, explicit and 51 
judicious use of the best scientific evidence to inform clinical decisions with a view to 52 
improve the clinical outcome at the individual level (2-3). However, in the veterinary 53 
profession, a great deal of time is spent in making diagnostic, therapeutic and preventive 54 
decisions in a complex and uncertain environment where optimal evidence often lacks (4).  55 
Medical care is the art of making decisions without adequate information (5). Medical 56 
decision making has been studied extensively and follows a mainstream trend, labelled 57 
„rational optimising‟ (6). It is usually based on cognitive rational models, such as decision 58 
analysis, decision tables, decision trees and Bayes‟ theorem (7-11). When decision refers to 59 
diagnosis, the consideration of the possible causes of a disease, its prevalence and an initial 60 
evaluation of clinical signs will lead to a differential diagnosis about which clinical judgment, 61 
informed by evidence clinical data, is exercised (3). Diagnosis may involve the choice and 62 
interpretation of an appropriate confirmatory diagnostic test.
 63 
To detect and identify emerging or rare diseases, a good clinical approach is essential 64 
as few biological and epidemiological data and\or laboratory tests are available. The approach 65 
aims at establishing the limits between normality and abnormality as veterinarians cannot 66 
relate the clinical signs to those of a known disease or to their experience. These limits should 67 
be built on the ability to detect biological variations in physiological and environmental 68 
conditions. The various actors involved in epidemiosurveillance networks (e.g. breeders, 69 
veterinarians, and slaughterhouse staff) should be prepared to this clinical approach to fulfil 70 
their responsibility in health monitoring (12). Part of this training should develop knowledge 71 
of disease biology and epidemiology, and skills in a rigorous, standardized and evidence-72 




 However, since with emerging diseases, the implementation of classical EBVM is 74 
difficult because few published cases are available and/or accessible via web searches, other 75 
options are necessary. 76 
The current paper aims to describe a method to improve the early clinical detection of 77 
emerging diseases in food animals and zoonoses. This approach is based on the analysis of 78 
field clinical observations collected on the first cases suspected of disease using a method 79 
called “classification and regression tree” (CART) (17-19). Those clinical facts become the 80 
only evidences available. Two practical examples are developed to illustrate the feasibility of 81 
the method in cattle. Future prospect is also proposed like the implementation of a structured, 82 
well-informed and interactive veterinary web clinical data mining platform. 83 
 84 
CASE DESCRIPTION 85 
Two examples are developed to illustrate the use of CART analysis for stimulating the 86 
early warning of emerging animal diseases. This is a key parameter of health control strategy 87 
(20). CART analysis is a non-linear and non-parametric model fitted by binary recursive 88 
partitioning of data (including clinical signs). Using CART 6.0 software (Salford Systems, 89 
San Diego, CA, USA), the analysis successively splits the dataset into increasingly 90 
homogeneous subsets until it is stratified and meets specified criteria (clinical signs) (Figure 91 
1). Further details about CART are presented in previously original papers or reviews (17-19, 92 
21).
 93 
Case 1: Early detection of bovine spongiform encephalopathy 94 
Background: Bovine spongiform encephalopathy (BSE) emerged in 1986 (22). It is a 95 
neurodegenerative disease characterised by a very long incubation period compared to the life 96 
of the host species (23). BSE started a dramatic chain of events in the United Kingdom and 97 
subsequently in other countries (24). The peak of interest was the discovery of its potential 98 
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zoonotic character after the first description of a new variant of Creutzfeldt-Jakob disease 99 
(CJD) in 1996 (25-27). The presence of clinical signs seems to be linked to the localisation 100 
and degree of vacuolisation of neurones. The main warning signs are psychic disorders 101 
(apprehension, temperament change, abnormal ear position and abnormal behaviour), sensory 102 
disorders (exaggerated responses to stimuli, excessive licking) as well as postural and 103 
locomotion abnormalities (ataxia and tremors). Their identification requires a clinical 104 
approach: a thorough veterinary clinical examination of the animal when on a halter and when 105 
moving in an uncustomary environment (16).
 106 
Now the evolution of BSE incidence in many European countries is in decline (28). Because 107 
of the favourable BSE epidemiological situation of most Member States in the European 108 
Union, a lowering of control measures, by reducing testing procedure, was recently suggested. 109 
However, in such a context, the reporting of clinically suspected cattle by the veterinarians is 110 
the most common method for detecting sporadic cases of BSE (18). The improvement of 111 
clinical diagnosis and decision-making remains crucial.  112 
Veterinary data collection: A comparison of clinical patterns captured by veterinarians, 113 
consisting in 25 signs, was carried out between BSE cases confirmed in Belgium before 114 
October 2002 (N = 30), and 272 suspected cases that were subsequently determined to be 115 
histologically, immunohistochemically, and scrapie-associated-fiber negative (10).  116 
Epidemiological methods and principal findings: Seasonality in reporting suspected cases 117 
was observed, with more cases being reported during wintertime when animals were kept 118 
indoors. The median duration of illness was 30 days. Using odds ratio, the 10 most relevant 119 
signs of BSE were kicking in the milking parlour, hypersensitivity to touch and/or sound, 120 
head shyness, panic-stricken response, reluctance to enter in the milking parlour, abnormal ear 121 
movement or carriage, increased alertness behaviour, reduced milk yield, teeth grinding and 122 
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temperament change. Ataxia did not appear to be a specific sign of BSE. A classification and 123 
regression tree was constructed by epidemiologists using the following four features: age of 124 
the animal, year of birth, number of relevant BSE signs noted, and number of clinical signs 125 
typical of listeriosis reported. The model presented a 100% sensitivity and a 85% specificity 126 
(Figure 2).  127 
Veterinary significance: The originality of the approach resides in the fact that, first; it 128 
involved both veterinarians and epidemiologists. Secondly, it offers an explorative and 129 
interactive tool based of clinical observations (evidences) captured by veterinarians and, then, 130 
the results and conclusions arrived at are independent of BSE prevalence, through the use of 131 
odds ratios. The late feature is especially appealing for rare events. A similar decision tree, 132 
allowing the distinction of ‟highly suspected BSE cases‟ from all other suspected BSE cases, 133 
could be applied in other countries, with or without the use of rapid tests. The continued 134 
addition of standardized clinical data by veterinarians would permit further improvement of 135 
the current model tree, even if the clinical BSE pattern would be modified in time. Based on 136 
the CART analysis results, veterinarians could more appropriately identify affected cows and 137 
retrieve them from the food chain in a public health perspective. 138 
Case study 2: Early detection of bluetongue 139 
Background: Bluetongue (BT) is a non-contagious disease affecting ruminants and is caused 140 
by the bluetongue virus (BTV). BTV is transmitted by blood-feeding midges of the genus 141 
Culicoides (Diptera: Ceratopogonidae) (29). A broad spectrum of wild and domestic 142 
ruminants can be infected and severe clinical signs are mainly seen in certain breeds of sheep 143 
and some Cervidae species (30-31). The severity of infection depends on various factors, such 144 
as species, breed, age, nutritional and immune status of animals, and environmental stresses, 145 
as well as the virulence of the BTV strain involved (32). Although clear differences in 146 
virulence of BTV isolates are known, the determinants of virulence are still poorly defined 147 
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(32). Clinical manifestations are closely linked to virus-induced vascular injuries and the role 148 
of species-specific endothelial cell-derived inflammatory and vasoactive mediators has been 149 
highlighted (33). The European BTV-8 outbreak was characterised by peculiar features (34). 150 
Among these features, a remarkable severity of the lesions in cattle was noticed (35).
 
151 
Veterinary data collection: Forty-one cattle from seven Belgian farms and two French farms 152 
confirmed as infected with bluetongue virus serotype 8 (BTV-8) were monitored from the 153 
onset of clinical signs in order to describe the disease pattern (19). On each visit, a 154 
standardised clinical form was filled in for each animal by a veterinarian (Table I) (36).  155 
Epidemiological methods and principal findings: A clinical score was calculated for every 156 
week until the end of clinical signs. A CART analysis was conducted by epidemiologists to 157 
determine the most important clinical signs every week for the first seven weeks. The highest 158 
scores were recorded within two weeks of clinical onset. The first recorded clinical signs were 159 
quite obviously visible (conjunctivitis, lesions of nasal mucosa and nasal discharge). Skin 160 
lesions, a drop in milk production and weight loss appeared later in the course of the disease. 161 
A biphasic pattern regarding nasal lesions was noticed: the first peak concerned mainly 162 
congestive and ulcerative lesions, whereas the second peak mainly concerned crusty lesions.  163 
Veterinary significance: These results should ensure a more accurate detection of BT in 164 
cattle by veterinarians in order to increase the early detection of emerging diseases (Table II). 165 
 166 
DISCUSSION AND CONCLUSION 167 
The clinical expression of a disease in an animal depends on several parameters: the 168 
nature of the causal agent (dose, virulence) (37), the location of induced lesions (38), the host 169 
(resistance, general condition, immune status) and the environment; certain clinical signs may 170 
be exacerbated when the environment of the animal is altered (39-40). The quality of 171 
observation plays an essential role and is proportional to the breeders‟ and veterinarians‟ level 172 
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of information, awareness and training. The intensity of observation is also important, and 173 
seems to depend directly on herd size. According to the United States of America, National 174 
Animal Health Monitoring System (NAHMS), the rate of neurological problems in breeding 175 
females in beef herds, expressed in affected cattle per thousand, doubles when herd size is less 176 
than 100 heads, and is nil when herd size is over 300 heads (41). In addition to these 177 
parameters, there is a degree of variability that depends on the individual animal and the 178 
observer (clinical picture, pre-patent phase and course of the disease). To improve knowledge 179 
regarding diseases, especially (re-)emerging animal diseases, it is important: i) to improve 180 
awareness, training and information available for breeders and veterinarians, ii) to use a 181 
uniform method for clinical examination by veterinarians, iii) to make more systematic use of 182 
confirmatory diagnostic tests, iv) to create sentinel networks of highly-motivated breeders and 183 
veterinarians, v) to transcribe the results of observations in a codified and standardised form, 184 
regarding both nature and course, vi) to compile and validate existing information by 185 
epidemilogists vii), to enrich a relational database and viii), to discuss actual experience in a 186 
focus group.  187 
In case of early clinical detection of emerging animal diseases, an EBVM approach is 188 
difficult to perform. However an alternative approach based on new structured and 189 
harmonized clinical observations (evidence) should be used (standardized clinical form 190 
compiled by veterinarians). With two practical examples we demonstrated the usefulness of 191 
joint effort involved veterinarians and epidemiologists in CART analysis to improve the early 192 
clinical detection of (re-) emerging animal diseases. The strategy is based on analysis of 193 
clinical observations (evidences) captured by veterinarians in the field. Selection criteria are 194 
based on signs captured by a structured and harmonized clinical form. A presumptive clinical 195 
diagnosis performed by veterinarians implies confirmatory diagnostic test(s). Results are 196 
analyzed taking into account all clinical signs registered. The CART analysis carried out by 197 
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epidemiologists allows producing a robust clinical tree that improves the early clinical 198 
detection of diseases by any veterinarian who has not faced the considered emerging disease 199 
before.   200 
The CART approach is characterised by i) its exploratory and interactive aspects, ii) 201 
its independence from sample size and disease prevalence, which is usually imperfectly 202 
known, and iii), its spatio-temporal universality (adaptation is possible when the clinical 203 
profile of disease evolves in function of time or region; adaptation is also possible for other 204 
diseases). The use of tools to improve the detection of (re-)emergent diseases will lead to 205 
more effective veterinary epidemiosurveillance networks. The efficacy of these networks 206 
requires regular evaluations together with the elaboration and a continuous follow-up of 207 
performance indicators. The recent episodes of both human and animal (re-)emergent diseases 208 
have also highlighted the important role of global health information systems. These systems 209 
require abilities, resources, collaborative and coordinated actions of medical and veterinary 210 
regulatory authorities. 211 
To improve early clinical detection of (re-)emerging diseases, a future prospect should 212 
consist in developing a veterinary structured and informed clinical platform. Whilst some 213 
interesting diagnostic support systems for veterinary medicine exist, like the “Consultant” 214 
support system from the Cornell College of Veterinary Medicine (http: 215 
www.vet.cornell.edu/consultant/consult.asp) (42), no interaction and partition of clinical data 216 
are currently available.  217 
Facing the emergence of diseases, the translation of the support system to an interactive 218 
platform should be interesting. Involving sentinel veterinarians in this platform is crucial. 219 
Veterinarians should be stimulated in a pilot research project to ensure the collection of field 220 
clinical data through the filling of structured and harmonized clinical forms. The connection 221 
between validated clinical data and results of confirmatory diagnostic tests using CART 222 
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analysis by epidemiologists permits to build useful clinical decision trees to improve the 223 
evidence-based early clinical detection of diseases of food-producing animals in the field. 224 
More interactions between veterinarians and epidemiologists should be stimulated in a 225 
clinical perspective. 226 
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Figures and tables 356 
 357 
Figure 1. Flowchart of the CART approach with implication of veterinarians (on the left: 358 
process; on the right: actors involved) 359 
 360 
Figure 2. Classification and regression tree modelling for clinically suspected bovine 361 
spongiform encephalopathy cases in Belgium (10) 362 
Legend: BSE, bovine spongiform encephalopathy; LIS, listeriosis; Score, number of clinical 363 
signs that are present. 364 
 365 
Table I. Bluetongue standardized clinical form for the use in different species (36) 366 
 367 
Table II. Variable importance in CART analysis during the first seven weeks of cattle 368 




Table I. Bluetongue standardized clinical form for the use in different species (36) 371 
General information: Identification number of the herd; Identification number of animal; 
Animal species; Breed; Sex; Date of birth; Date of last calving; Stage of pregnancy; Date of 
clinical examination; Name of clinician.  
General clinical signs: Hyperthermia; Decreased milk production; Wasting, emaciation, 
weight loss; Tiredness; Oedema of head, ears, sub-mandibular region, or the peri-orbital 
region; Hypertrophied lymph nodes.   
Clinical signs of skin and annexes: Lesions of the muzzle, lips (congestion > ulcers > 
necrosis); Conjunctivitis, tears, peri-ocular dermatitis; Photosensibilisation-like lesions; 
Presence of petechias, contusions, ecchymoses; Erythema, inflammation of the skin, crusts; 
Cyanosis of the skin or limbs;  Skin lesion of the udder, teats or vulva; Scrotal skin lesions; 
Wool loss (sheep). 
Clinical loco-motor signs (musculo-artho-skeletal): Incapacity to lift up or prostration; 
Reluctance to move or limited movement; Lameness, stiffness of front limbs; Lameness, 
stiffness of hind limbs; Oedema of coronary bands; Swelling of pastern, fetlock, cannon, 
carpal or hock joint; Pododermatitis; Contracture of front limbs; Contracture of hind limbs; 
Arched back; Amyotrophy; Torticollis or neck bended. 
Digestive clinical signs: Loss of appetite; Anorexia; Difficulties in grasping the food; 
Regurgitation; Congestion, erythema of the oral mucosa; Ulcerative lesions of the oral 
mucosa, excoriations; Salivation, drooling, foam out of the mouth; Oedema and/or protrusion 
of the tongue; Cyanosis of the tongue; Haemorrhagic stool; Diarrhoea. 
Respiratory clinical signs: Ulcerative lesions of the nasal mucosa; Purulent nasal discharge; 
Mucous, serous, aqueous nasal discharge; Halitosis or bad breath; Dyspnoea, oral breathing, 
stridor.   
Neurological clinical signs: Apathy, lethargy; Generalised weakness, paresis or paralysis. 
Reproductive clinical signs: Anoestrus; Abortion or premature calving; Stillbirth; 
Abnormalities of newborns. 
Duration of evolution: Date of the first clinical signs; Comments on the evolution of the 
disease within the herd. 
Post-mortem (PM): Has a PM examination been performed?; If « yes », please attach a 
copy of the PM record(s) (with the animals identification mentioned). 
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 Ulcerative lesions of nasal mucosa, crusts  32 100 100 91 
  
76 











 Loss of appetite 18 
 
71 18 3 28 27 





Ulcerative lesions of buccal mucosa, excoriation 11 
 
24 44 0 
 
0 
Swelling of coronary bands 7 
    
62 
 Skin lesions of udder, teat or vulva 1 
  
9 32 18 





 Lameness or generalised stiffness 










   
6 
   Tiredness, limited walking 




 Salivation, ptyalism, mouth foam 




 Weight loss 
  
3 62 100 5 41 
Arching of back 
  
3 
    Muscular atrophia 
  
9 36 
   Anoestrus 





   
34 69 78 100 





Figure 1.  378 
 379 




Clinical sign #1  
Clinical sign #2  
Clinical sign #3  
Clinical sign #4  
Clinical sign #5  
Absence Presence
Clinical sign #1  
Clinical sign #2  
Clinical sign #3  
Clinical sign #4  
Clinical sign #5  
Absence Presence
Clinical sign #1  
Clinical sign #2  
Clinical sign #3  
Clinical sign #4  
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